Skip to main content

4 Result(s)

within Thomas Broge Remove this filter

and

  1. No Access

    Article

    Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV

    Antibodies are the primary correlate of protection for most licensed vaccines; however, their mechanisms of protection may vary, ranging from physical blockade to clearance via the recruitment of innate immuni...

    Margaret E. Ackerman, Jishnu Das, Srivamshi Pittala, Thomas Broge… in Nature Medicine (2018)

  2. No Access

    Article

    Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

    The latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection. Previous studies have shown direct antiviral activity of potent HIV-1 Env-specific broadly neutralizing ant...

    Erica N. Borducchi, **yan Liu, Joseph P. Nkolola, Anthony M. Cadena, Wen-Han Yu… in Nature (2018)

  3. Article

    Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys

    In Fig. 4b of this Article, the x-axis labels ‘PGT121’ and ‘GS-9620’ were inadvertently swapped in both graphs. In Fig. 5a, b, ‘TLR7’ should have been ‘GS-9620’. These figures have been corrected online.

    Erica N. Borducchi, **yan Liu, Joseph P. Nkolola, Anthony M. Cadena, Wen-Han Yu… in Nature (2018)

    Download PDF (503 KB) View Article

  4. Article

    Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics

    The emergence and re-emergence of highly virulent viral pathogens with the potential to cause a pandemic creates an urgent need for the accelerated discovery of antiviral therapeutics. Antiviral human monoclon...

    Pavlo Gilchuk, Robin G. Bombardi, Jesse H. Erasmus… in Nature Biomedical Engineering (2020)

    Download PDF (2517 KB) View Article